Future-Proofing Analysis of the 2017 EU AMR Action Plan

Abstract Antimicrobial resistance (AMR) is a serious public health concern and has been deemed a top priority amongst public health authorities internationally. AMR is a complex issue, which is affected by a wide range of diverse factors including antimicrobial use, vaccines, surveillance, climate change and global conflicts. In thinking about how to address AMR, it is important to not only consider how multiple factors interact to contribute to the issue, but also how these factors may develop in the future. In 2017, the European Commission published the European One Health Action Plan against AMR, which set out objectives and priory areas for actions across EU/EEA Member States. This presentation will discuss the results of a future proofing study of this Plan. The study included a series of scenarios for how AMR might develop over the next ten years, in order to gather stakeholder perspectives on how the Plan can be improved to mitigate against future risks, take advantage of future opportunities and move towards more favorable futures. In particular, this presentation will focus on how this futures method was used to arrive at specific and actionable recommendations about how to better prepare for the future of AMR.